Balyasny Asset Management
AMED

Balyasny Asset Management’s Amedisys AMED Stock Holding History

Balyasny Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,400
Closed -$1.5M – 2223
2023
Q2 		$1.5M Buy
+16,400
New +$1.35M ﹤0.01% 1472

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's AMED Position: Q3 2025 in Review

Balyasny Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 641,299 shares — an estimated $63.1M sold.

Balyasny Asset Management first reported a position in AMED in Q2 2017 and held it in 17 quarters. The position peaked at $63.1M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Balyasny Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 641,299 Amedisys shares in Q3 2025, an estimated $63.1M.
  • Balyasny Asset Management first reported a position in Amedisys in Q2 2017 and held it in 17 quarters.
  • Balyasny Asset Management's Amedisys position peaked at $63.1M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.